A new study published in the journal of BMC Pulmonary Medicine showed that 10% of psoriasis patients would have interstitial ...
Psoriasis affects 2% of the U.S. population ... the main reason for CAM use was "to do everything to heal the disease," followed by a desire for improved quality of life (Ben-Arye, Ziv, Frenkel ...
Psoriasis is a complicated disease driven by inflammation. This inflammation is thought to extend beyond the skin and may lead to problems throughout the body for many people. An increasing amount ...
Most people have only one type at a time. Experts believe psoriasis is an autoimmune disease. It means your body thinks its own tissues are foreign invaders to be attacked. With psoriasis ...
Joel Thomas works hard at his job as an I-T specialist. He also works hard to stay healthy despite his history of psoriasis. Joel Thomas I have an echocardiogram done every year just to make sure ...
IT’S not often that one sees avant-garde dresses being displayed at a medical conference, but that was certainly the case during the recent 25th World Congress of Dermatology in Singapore.
are consistent with porcine juvenile pustular psoriaform dermatitis (PJPPD) 1. Figure 2: Photomicrographs of adjacent sections of haired skin over a lesion from the pig in Figure 1, stained with ...
Skyrizi is important for AbbVie as sales of its Humira (adalimumab) inflammatory disease mega-blockbuster ... a licence for plaque psoriasis, generalised pustular psoriasis, erythrodermic ...
There are two major forms of psoriasis: plaque psoriasis, the more common one, and pustular psoriasis, the more severe but ...
German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...
Secukinumab is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.